| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af92759c928daeb7f0daabbb0499f059 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N1-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J43-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-163 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-06 |
| filingDate |
2018-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d810a17393cb1532b9dad8c1d40565e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6681e1a5567d9b5fe23e46c1d1a24281
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_392c82376b108093d794895dda3d8de9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5d3078dc58e9814fee0c5df07a5552f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bd5b66e0f9ac2710ce2f29663f46e59 |
| publicationDate |
2020-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3604517-A1 |
| titleOfInvention |
Anti-apoa1 antibody |
| abstract |
An object of the present invention is to acquire an antibody capable of binding to high-density lipoprotein regardless of the modified state of high-density lipoprotein and whether or not it incorporates labeled cholesterol. Provided is a monoclonal antibody or antigen-binding fragment thereof which binds to a peptide consisting of 51st to 110th amino acid sequence or a peptide consisting of 201st to 267th amino acid sequence of an amino acid sequence of SEQ ID NO: 1, and is capable of binding to high-density lipoproteins of (1) to (3) below;(1) high-density lipoprotein that is oxidatively modified,(2) high-density lipoprotein that is not oxidatively modified, and(3) high-density lipoprotein incorporating labeled cholesterol. |
| priorityDate |
2017-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |